Northwire Canada EditionWednesday, July 15, 2026
Sign inSubscribe
Northwire
⌕
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%

Healthcare

Page 60
  1. Feb 18, 2026 · 07:19 · APLI

    Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

    Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

    01
  2. Feb 18, 2026 · 07:01 · TELO

    Telo Genomics Closes First Tranche of Convertible Debentures Financing

    Telo Genomics Closes First Tranche of Convertible Debentures Financing

    02
  3. Feb 18, 2026 · 06:58 · BLCO

    Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance

    Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance

    03
  4. Feb 17, 2026 · 18:43 · HELP

    Cybin's phase 2a data published in Nature Medicine

    Cybin's phase 2a data published in Nature Medicine

    04
  5. Feb 17, 2026 · 18:29 · BCT

    Briacell receives recommendation from safety board

    Briacell receives recommendation from safety board

    05
  6. Feb 17, 2026 · 17:52 · SPLY

    Safe Supply to sell two Nirlab devices to first nation

    Safe Supply to sell two Nirlab devices to first nation

    06
  7. Feb 17, 2026 · 17:50 · KNE

    Kane Biotech passes regulatory "milestones"

    Kane Biotech passes regulatory "milestones"

    07
  8. Feb 17, 2026 · 17:40 · TLT

    Theralase to present bladder cancer data set at EAU26

    Theralase to present bladder cancer data set at EAU26

    08
  9. Feb 17, 2026 · 11:33 · BNXT

    Bionxt obtains European patent for MS drug tech

    Bionxt obtains European patent for MS drug tech

    09
  10. Feb 17, 2026 · 09:00 · GSD

    Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

    Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

    10
  11. Feb 17, 2026 · 08:00 · ZCT

    Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device

    Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device

    11
  12. Feb 17, 2026 · 07:30 · HELP

    Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder

    Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder

    12
  13. Feb 17, 2026 · 07:30 · BCT

    BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

    BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

    13
  14. Feb 17, 2026 · 07:25 · KNE

    Kane Biotech Announces FDA 510(k) Clearance for revyve(TM) Antimicrobial Skin and Wound Cleanser

    Kane Biotech Announces FDA 510(k) Clearance for revyve(TM) Antimicrobial Skin and Wound Cleanser

    14
← Newer Older →